← Scroll for more →
CytomX Therapeutics, Inc. (CTMX)
Pharmaceutical Preparations
Latest Price
$2.72
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
1.39
P/B Ratio
1.96
Institutional Ownership
98.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| FMR LLC | 32.71M | $122.0M | 14.94% | +759.3K | 2026-06-30 |
| Kynam Capital Management, LP | 21.70M | $81.0M | 9.91% | +6.69M | 2026-06-30 |
| BlackRock, Inc. | 17.56M | $65.0M | 8.02% | +12.33M | 2026-06-30 |
| Bank of America Corp | 15.08M | $56.0M | 6.89% | +4.88M | 2026-06-30 |
| State Street Corp | 11.75M | $44.0M | 5.37% | +6.08M | 2026-06-30 |
| Perceptive Advisors LLC | 10.44M | $39.0M | 4.77% | +340.4K | 2026-06-30 |
| Vanguard Capital Management LLC | 8.53M | $31.0M | 3.89% | -207.7K | 2026-06-30 |
| Point72 Asset Management, L.P. | 7.81M | $29.0M | 3.57% | -64.4K | 2026-06-30 |
| Wellington Management Group LLP | 5.17M | $19.0M | 2.36% | +1.59M | 2026-06-30 |
| Venrock Adviser, LLC | 4.98M | $18.0M | 2.28% | -5.00M | 2026-06-30 |